Invetx: Funding, Investors & Team (Sep 2026)
Invetx is a veterinary therapeutics company that focuses on biopharmaceuticals that bring human biotechnology to animal health. Invetx is building the world’s premier animal health biotechnology innovation platform for protein-based therapeutics. Working closely with best-in-class biotechnology companies, major investors and an extensive network of industry experts, Invetx is focused on guiding the development of an exciting portfolio of therapies and technologies to deliver the future of animal care. Invetx's network includes experts in both animal and human health, veterinary scientists and clinicians. The company's vision is of a global animal health industry that fully leverages biopharma technologies to deliver dramatically improved health outcomes for pets and farm animal populations.
Invetx has raised $116M across 2 funding rounds on record, the most recent a Series B of $60.5M announced in May 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Invetx Company Profile and Key Stats
Latest funding round on record: May 2022.
Invetx Funding Rounds
Invetx raised $55.5M in an undisclosed round announced in Apr 2022.
1 month later, a Series B of $60.5M was announced in May 2022.
Invetx Founders and Leadership Team
Contact details for the Invetx team: 1 of 1 has an email address on file.
Start 14-day free trial →Invetx Funding Compared to Other Biotechnology Startups
Invetx's latest round of $60.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Invetx in Biotechnology and Boston
Companies Similar to Invetx
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Invetx Funding FAQs
What does Invetx do?
Invetx is a veterinary therapeutics company that focuses on biopharmaceuticals that bring human biotechnology to animal health. Invetx is building the world’s premier animal health biotechnology innovation platform for protein-based therapeutics. Working closely with best-in-class biotechnology companies, major investors and an extensive network of industry experts, Invetx is focused on guiding the development of an exciting portfolio of therapies and technologies to deliver the future of animal care. Invetx's network includes experts in both animal and human health, veterinary scientists and clinicians. The company's vision is of a global animal health industry that fully leverages biopharma technologies to deliver dramatically improved health outcomes for pets and farm animal populations.
How much funding has Invetx raised?
Invetx has raised $116M across 2 rounds on record. The most recent is a Series B of $60.5M announced in May 2022.
When did Invetx last raise funding?
Invetx's most recent funding round on record is a Series B of $60.5M, announced in May 2022.
Who is the CEO of Invetx?
Juergen Horn is listed as CEO at Invetx.
Where is Invetx headquartered?
Invetx is based in Boston, Massachusetts, United States.
How many employees does Invetx have?
Invetx is in the 1-10 employee band.
How does Invetx's funding compare to other Biotechnology startups?
Invetx's latest round of $60.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Invetx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Invetx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.